JNCI Journal of the National Cancer Institute · 1973 · 67 citations · 0 references
Life SciencesImmunologyCancer ImmunologyCellular ImmunologyTumor ImmunologyAntitumor T Cell ResponsesCancer ImmunotherapyCell-mediated ImmunityNatural Killer Cell BiologyNatural Killer Cell FunctionT Cell BiologyAdaptive Antitumor ImmunityAdjuvant-induced ImmunityAntitumor Immune ActivationCarbohydrate-based AdjuvantsT Cell Response InductionT-cell Mediated ImmunityT-cell PrimingT-cell Responses To Tumor Antigens
Lentinan, a linear β (1–3) glucan with antitumor activity was tested for its activity on various immune responses. Lentinan had only minor effects on the plaqueforming cell response to sheep red blood cells but significantly stimulated antibody-dependent, cell-mediated immunity. This effect was due to stimulation of T helper cell priming by Lentinan, which amplified antibody synthesis. Lentinan, however, could not be demonstrated to increase sensitization of T killer cells in an allogeneic system.